Newsroom
Sorted by: Latest
-
Dockwa Secures Strategic Growth Investment from PSG to Build the Operating System for the $57 Billion Marina Economy
NEWPORT, R.I.--(BUSINESS WIRE)--Boating is one of the last great consumer categories to digitize. Dockwa, an operating system built for the $57 billion marina economy, today announced a strategic growth investment from PSG, a leading growth equity firm that partners with software and technology-enabled services companies to help navigate transformational growth. For Dockwa, the investment lands at an inflection point for an industry institutional capital is just discovering. Over the past decad...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: SCOTLAND GAS NETWORKS PLC GBP 80,000,000.00 MATURING: 10-Mar-2043 ISIN: XS0348776294 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 10-Mar-2026 TO 10-Jun-2026 HAS BEEN FIXED AT 4.87 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 10-Jun-2026 WILL AMOUNT TO: GBP 12.27 PER GBP 1,000.00 DENOMINATION ...
-
Milliman analysis: Public pension funded ratio rebounds to 87.6% as April gains erase March losses
SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its monthly Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. The funded status of the Milliman PPFI plans improved by $266 billion during April, driven by estimated aggregate investment returns of 4.7% for the period. This lifted the plans’ funded ratio to 87.6% as of April 30—in stark contrast to the 8...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: Macquarie Bank Ltd Australia. USD 10,000,000.00 MATURING: 10-Mar-2027 ISIN: XS2454012647 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 10-Mar-2026 TO 10-Jun-2026 HAS BEEN FIXED AT 4.49 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 10-Jun-2026 WILL AMOUNT TO: USD 114,776.90 PER USD 10,000,000.00 DENOMINATION ...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: Banque Saudi Fransi USD 20,000,000.00 MATURING: 10-Mar-2032 ISIN: XS3019878035 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 10-Mar-2026 TO 10-Jun-2026 HAS BEEN FIXED AT 5.14 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 10-Jun-2026 WILL AMOUNT TO: USD 13.14 PER USD 1,000.00 DENOMINATION ...
-
AFYREN: Mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 16 juin 2026
CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), société de greentech qui offre aux industriels des produits biosourcés et bas-carbone grâce à sa technologie de fermentation unique basée sur un modèle complètement circulaire informe le public que son Assemblée Générale Mixte se tiendra le mardi 16 juin 2026 à 10h00, au sein des locaux de la Société situés Le Silex2 – City, 9 rue des Cuirassiers - 69003 Lyon. Les documents préparatoires à cette Ass...
-
Mauna Kea Technologies annonce une nouvelle publication dans le UEG Journal identifiant la « triple guérison » comme cible thérapeutique évaluée par Cellvizio®, prédictive d’une rémission durable dans la rectocolite hémorragique
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth : ALMKT) (la « Société ») inventeur de Cellvizio®, la plateforme multidisciplinaire d'endomicroscopie confocale laser par minisonde et par aiguille (p/nCLE), annonce aujourd’hui la publication d’une étude prospective dans le United European Gastroenterology Journal (Minea et al.1) qui renforce le positionnement de Cellvizio® comme un outil différenciant pour prédire la rechute dans la rectocolite hémorragi...
-
Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying “Triple Healing”, a Cellvizio®— Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Colitis
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today highlighted the publication of a prospective study in the United European Gastroenterology Journal (Minea et al.1) that strengthens the case for Cellvizio as a differentiated tool to predict relapse in ulcerative colitis (UC). The study introduces “triple healing” as a new th...
-
Spring Wellness Starts Within: Why Genestra Brands’ Targeted Probiotics Are a Seasonal Must-Have
TORONTO--(BUSINESS WIRE)--As Canadians move into a new season, Genestra Brands is putting gut health in the spotlight as the foundation of a true spring reset. With nearly 70% of the immune system linked to the gut, its HMF (Human Microflora) probiotic line – with 15+ different research driven formulas – ditches the one-size-fits-all approach to truly support the unique needs of each person’s gut microbiome. Raising the bar on what a daily probiotic can do, the HMF lineup supports everything fr...
-
Experienced Advisory Team With $160 Million in Assets Joins Ameriprise Financial for Enhanced Client Experience and Advanced Capabilities
MINNEAPOLIS--(BUSINESS WIRE)--Pattern Wealth, a private wealth advisory practice, recently joined the branch channel of Ameriprise Financial, Inc. (NYSE: AMP) from Thrivent Investment Management, Inc. with $160 million in client assets. The practice, located in Wayzata, Minn., is led by private wealth advisor Jeremy Jackson and includes his father, financial advisor Dave Jackson, and client service associate Erika Holland. The team, which brings decades of combined industry experience, chose to...